KIRA BARONDEAU: Open Payments
NPI 1215604012 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 45 payments from 20 companies in 2025. Trend: 2023 $2,138 · 2024 $1,204 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 6 | $167 |
| TG Therapeutics, Inc. | 3 | $167 |
| UCB, Inc. | 5 | $151 |
| Medtronic, Inc. | 1 | $144 |
| ABBVIE INC. | 7 | $136 |
| Celgene Corporation | 3 | $59 |
| Amneal Pharmaceuticals LLC | 2 | $55 |
| ACADIA Pharmaceuticals Inc | 2 | $54 |
| SK Life Science, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $45 |
Products named: VYVGART HYTRULO, BRIUMVI, PERCEPT PC BRAINSENSE, Rystiggo, ZEPOSIA, UBRELVY, QULIPTA, NUPLAZID.
Industry payments across UT — which companies pay providers there.
